Bashar Issa

Shift4's is on a fast track, with revenue and EPS making leaps. Despite its growth, its stock price looks undervalued. Find out why FOUR stock is a Buy.

Bashar Issa Summary Shift4's is on a fast track, with revenue and EPS making leaps. Despite its growth, Shift4's stock price looks undervalued.

Exact Sciences' unique regulatory advantage and the growth of Cologuard make it a strong contender. Click here to read an analysis of EXAS stock here.

Bashar Issa Summary EXAS has a unique regulatory advantage as the FDA and Congress work on extending the regulatory arm over the gene diagnostics sector.

Bashar Issa Summary GigaCloud Technology Inc. has demonstrated an inconsistent strategic vision since its 2006 founding.

Bashar Issa Summary Medical Properties Trust's focus on hospitals funded by private equity bankers introduces unique risks that are different from those of a typical operator.

Tesla's stock value is threatened by the smaller-than-expected overall EV market, causing concern for its future sales. Explore more details here.

PayPal is clearly playing defensive in a market it once dominated. Read more to see my analysis of PYPL stock and why it's a hold.

Bashar Issa Summary PayPal is facing significant challenges as fintech rivals and increasingly tech-savvy banks expand into its territory.

Bashar Issa Summary Plug Power Inc.'s shares have declined by 40% since the last article, but rallied on news of a $1.66 billion loan for hydrogen production plants.